Evidence map›Paper›PMID 42514031›Full record

ArticleMicroorganisms2026

Tiered Functional Screening Identifies an Autochthonous Vaginal

Viktoria Nazarova, Nazira Kamzayeva, Samat Kozhakhmetov, Almagul Kushugulova, Milan Terzic, Gauri Bapayeva, Berik Primbetov, Balkenzhe Imankulova, Gulzhanat Aimagambetova, Yevgeniy Kim and 12 more

Abstract read
In one paragraph

Article in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Viktoria NazarovaLaboratory of Microbiome, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.
Nazira KamzayevaClinical Academic Department of Women's Health, Corporate Fund "University Medical Center", Astana 010000, Kazakhstan.
Samat KozhakhmetovLaboratory of Microbiome, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0000-0001-9668-0327
Almagul KushugulovaLaboratory of Microbiome, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0000-0001-9479-0899
Milan TerzicClinical Academic Department of Women's Health, Corporate Fund "University Medical Center", Astana 010000, Kazakhstan.ORCID 0000-0003-3914-5154
Gauri BapayevaClinical Academic Department of Women's Health, Corporate Fund "University Medical Center", Astana 010000, Kazakhstan.ORCID 0000-0002-8344-7873
Berik PrimbetovClinical Academic Department of Women's Health, Corporate Fund "University Medical Center", Astana 010000, Kazakhstan.
Balkenzhe ImankulovaClinical Academic Department of Women's Health, Corporate Fund "University Medical Center", Astana 010000, Kazakhstan.
Gulzhanat AimagambetovaDepartment of Surgery, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0000-0002-2868-4497
Yevgeniy KimClinical Academic Department of Women's Health, Corporate Fund "University Medical Center", Astana 010000, Kazakhstan.ORCID 0009-0005-8040-325X
Kuralay KongrtayClinical Academic Department of Women's Health, Corporate Fund "University Medical Center", Astana 010000, Kazakhstan.ORCID 0000-0002-1405-2245
Nazira KadroldinovaClinical Academic Department of Women's Health, Corporate Fund "University Medical Center", Astana 010000, Kazakhstan.ORCID 0000-0003-4309-0432
Makhabbat GalymClinical Academic Department of Women's Health, Corporate Fund "University Medical Center", Astana 010000, Kazakhstan.
Sanimkul MakhambetovaClinical Academic Department of Women's Health, Corporate Fund "University Medical Center", Astana 010000, Kazakhstan.
Kadisha NurgaliyevaClinical Academic Department of Women's Health, Corporate Fund "University Medical Center", Astana 010000, Kazakhstan.
Zhanar AbdiyevaClinical Academic Department of Women's Health, Corporate Fund "University Medical Center", Astana 010000, Kazakhstan.
Zhanar ZhumakanovaClinical Academic Department of Women's Health, Corporate Fund "University Medical Center", Astana 010000, Kazakhstan.
Saule AkhmetovaDepartment of Biomedicine, Karaganda Medical University, Karaganda 100000, Kazakhstan.
Zhanerke AmirkhanovaDepartment of Biomedicine, Karaganda Medical University, Karaganda 100000, Kazakhstan.
Balnur SmagulovaDepartment of Obstetrics and Gynecology No. 1, Astana Medical University, Astana 010000, Kazakhstan.
Aidana TastanovaSchool of Sciences and Humanities, Nazarbayev University, Astana 010000, Kazakhstan.
Talshyn UkybassovaClinical Academic Department of Women's Health, Corporate Fund "University Medical Center", Astana 010000, Kazakhstan.

Funding

Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan BR24992853
6 · The paper itself

Abstract

Persistent high-risk human papillomavirus (HPV) infection drives cervical cancer, a leading cause of cancer-related mortality among women in low- and middle-income countries; its clinical course is shaped by the cervicovaginal microbiome, in which

Indexed as

autochthonous probioticbiofilm formationCentral Asiacervicovaginal microbiomeHPVLactiplantibacillus plantarumstrain-level functional screeningvaginal lactobacilli

Identifiers

PMID42514031
PMCPMC13414338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.